Compounds > melagatran
Page last updated: 2024-09-05

melagatran and Reperfusion Injury

melagatran has been researched along with Reperfusion Injury in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Belliard, A; Giraud, S; Goujon, JM; Hauet, T; Hebrard, W; Macchi, L; Manguy, E; Mauco, G; Milin, S; Nadeau, C; Thuillier, R1
Grimberg, E; Guron, G; Marcussen, N; Nitescu, N; Ricksten, SE1

Other Studies

2 other study(ies) available for melagatran and Reperfusion Injury

ArticleYear
Direct thrombin inhibitor prevents delayed graft function in a porcine model of renal transplantation.
    Transplantation, 2009, Jun-15, Volume: 87, Issue:11

    Topics: Animals; Anticoagulants; Azetidines; Benzylamines; Brain Death; Cell Survival; Creatinine; Heart Arrest; Kidney Transplantation; Male; Mitochondria; Models, Animal; Partial Thromboplastin Time; Renal Circulation; Reperfusion Injury; Reverse Transcriptase Polymerase Chain Reaction; Swine; Thrombin; Transplantation, Autologous; Transplantation, Homologous

2009
Thrombin inhibition with melagatran does not attenuate renal ischaemia-reperfusion injury in rats.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2007, Volume: 22, Issue:8

    Topics: Acute Disease; Animals; Anticoagulants; Azetidines; Benzylamines; Blood Coagulation; Body Weight; Kidney; Kidney Diseases; Kidney Function Tests; Male; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Thrombin; Thrombin Time

2007